Huber Capital Management LLC Boosts Position in Kenvue Inc. $KVUE

Huber Capital Management LLC increased its holdings in Kenvue Inc. (NYSE:KVUE) by 31.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 243,300 shares of the company’s stock after buying an additional 58,200 shares during the period. Huber Capital Management LLC’s holdings in Kenvue were worth $3,949,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in Kenvue in the 2nd quarter worth about $537,418,000. Independent Franchise Partners LLP boosted its position in Kenvue by 233.4% during the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after purchasing an additional 21,886,537 shares during the period. Van ECK Associates Corp raised its holdings in shares of Kenvue by 101.3% during the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after buying an additional 9,240,434 shares during the period. American Century Companies Inc. boosted its stake in shares of Kenvue by 38.6% in the second quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock valued at $633,447,000 after purchasing an additional 8,436,166 shares during the period. Finally, Amundi boosted its stake in shares of Kenvue by 82.5% in the second quarter. Amundi now owns 14,509,890 shares of the company’s stock valued at $305,446,000 after purchasing an additional 6,559,261 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on KVUE shares. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. UBS Group raised their price target on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Citigroup upped their price objective on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Canaccord Genuity Group increased their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Finally, Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. Based on data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus target price of $19.58.

Kenvue Price Performance

KVUE stock traded up $0.12 during trading on Friday, hitting $17.51. The company had a trading volume of 1,233,902 shares, compared to its average volume of 46,425,508. The business has a 50 day moving average of $17.89 and a 200 day moving average of $17.35. The firm has a market capitalization of $33.57 billion, a price-to-earnings ratio of 22.76, a P/E/G ratio of 4.01 and a beta of 0.51. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. During the same period last year, the company posted $0.26 EPS. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. As a group, research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were paid a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. Kenvue’s dividend payout ratio is currently 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.